Fast Market Research

Market Report, "ImQuest Life Sciences - Product Pipeline Review - 2013", Published

New Pharmaceuticals market report from Global Markets Direct: "ImQuest Life Sciences - Product Pipeline Review - 2013"


Boston, MA -- (SBWIRE) -- 10/07/2013 -- Global Market Direct's pharmaceuticals report, "ImQuest Life Sciences - Product Pipeline Review - 2013" provides data on the ImQuest Life Sciences's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, ImQuest Life Sciences's corporate website, SEC filings, investor presentations and featured press releases, both from ImQuest Life Sciences and industry-specific third party sources, put together by Global Markets Direct's team.


- ImQuest Life Sciences - Brief ImQuest Life Sciences overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ImQuest Life Sciences human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of ImQuest Life Sciences with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the ImQuest Life Sciences's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate ImQuest Life Sciences's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of ImQuest Life Sciences in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the ImQuest Life Sciences's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with ImQuest Life Sciences.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of ImQuest Life Sciences and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- LG Life Sciences, Ltd. - Product Pipeline Review - 2013
- Amorfix Life Sciences Ltd. - Product Pipeline Review - 2013
- Bioniche Life Sciences, Inc. - Product Pipeline Review - 2013
- Anavex Life Sciences Corp. - Product Pipeline Review - 2013
- ProMetic Life Sciences Inc. - Product Pipeline Review - 2013
- Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2013
- Connexios Life Sciences Pvt. Ltd. - Product Pipeline Review - 2013
- LG Life Sciences, Ltd. - Product Pipeline Review - 2012
- ProMetic Life Sciences Inc. - Product Pipeline Review - 2012
- Prostate Cancer - Pipeline Review, H2 2013